NDC 71449-116

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 71449-116
Product root: 71449-116
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	71449-116	71449-116-27	COMPOUNDER	Outsourcing facility compounded drug report	2020-1	2026-08-01
compounder	package	71449-116	71449-116-27	COMPOUNDER	Outsourcing facility compounded drug report	2019-2	2026-08-01

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
Denver Solutions, LLC dba Leiters Health	080586798	71449-116	71449-116-27	Adenosine; Lidocaine Hydrochloride; Magnesium Sulfate, Unspecified	2 mg/1 mL; 1 mg/1 mL; 100 mg/1 mL	2020-1	valid
Denver Solutions, LLC dba Leiters Health	080586798	71449-116	71449-116-27	Adenosine; Lidocaine Hydrochloride; Magnesium Sulfate, Unspecified	2 mg/1 mL; 1 mg/1 mL; 100 mg/1 mL	2019-2	valid